Potential inaccuracy of identification of DM onset may have led to under- or overestimation of the cumulative incidence of cancer; however, this is unlikely to have impacted the substantial difference in cancer incidence between the anti-TIF1-Ab-positive and -negative cohorts. Here, TRIM24 is linked to dermatomyositis.